T205 |
Lymphoma tissue array, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
NHL401a |
Lymphoma, myeloma and lymph node tissue array, 40 cases 40 cores, replacing NHL401; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
LM482a |
Lymphoma tissue array with normal lymph node tissue as control, 48 cases 48 cores, replacing LM482; ihc Anti-Actin confirmed
|
US Biomax |
|
320.00€ |
|
Pub |
LY121a |
Diffuse large B-cell lymphoma tissue array, 12 cases 12 cores, replacing LY121; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
LM801a |
Lymphoma tissue array with adjacent normal lymph node and spleen tissue as control, 80 cases 80 cores, replacing LM801; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
NHL802a |
Non-Hodgkin's lymphoma tissue array, 42 cases 80 cores, replacing NHL802; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
LY1001a |
Diffuse large-B cell lymphoma tissue array, 100 cases 100 cores, replacing LY1001; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
BR243e |
Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BC05118a |
Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BC05118; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
LV962 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
BN1002a |
Multiple organ normal tissue array, 100 cases 100 cores, replacing BN1002; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
T047 |
Non-small cell lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BCN963a |
Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases 96 cores, replacing BCN963; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
OV803a |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
T195a |
Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
GL241a |
Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases 24 cores, replacing GL241; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
MO541 |
Mouse multiple organ normal tissue array, 24 cases 54 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
162.00€ |
|
Pub |
ME1004a |
Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replacing ME1004; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
EN801a |
Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
ME803a |
Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases 80 cores, replacing ME803; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
FMC282a |
Multiple organ cancer frozen tissue array, including pathology grade, 28 cases 28 cores, replacing FMC282; ihc Anti-Actin confirmed
|
US Biomax |
|
394.00€ |
|
Pub |
T032a |
Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
ST801a |
Stomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases 80 cores, replacing ST801; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
ES1502 |
Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
RE1021 |
Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
T054a |
Colon cancer tissue array with normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T054; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
PA805a |
Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
BL1501 |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
UT961 |
Endometrium cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
ME2082a |
Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmed
|
US Biomax |
|
429.00€ |
|
Pub |
ES962 |
Esophageal squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
BR1005a |
Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
LC10010a |
Lung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases 100 cores, replacing LC10010; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
CO962 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
T141a |
Pancreas cancer test tissue array, including TNM and pathology grade, 6 cases 24 cores, replacing T141; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BR963a |
Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
FMC405a |
Multiple organ cancer frozen tissue array, including pathology grade, 40 cases 40 cores, replacing FMC405; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
LC726a |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
T176 |
Brain tumor tissue array, including pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BN243a |
Multiple organ normal tissue array, 12 cases 24 cores, replacing BN243; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
SK961 |
Skin tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
UT1501 |
Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
FDA808a-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing FDA808-2; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
OV1005a |
Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
T214 |
Skin tumor tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
PR243a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR243; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
T095 |
Endometrium cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
MBN481 |
Multiple organ normal tissue array, 48 cases 48 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
ME481a |
Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases 48 cores, replacing ME481; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
OV241a |
Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
LV1502 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
T046 |
Lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
CO242a |
Colon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO242; ihc Anti-Actin confirmed
|
US Biomax |
|
81.00€ |
|
Pub |
ES481 |
Esophageal cancer tissue array with matched or unmatched normal adjacent tissues (18 cases 48 cores) with stage and grade info; ihc Anti-Actin confirmed
|
US Biomax |
|
210.00€ |
|
Pub |
PM2-ER |
ER Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer and IHC results of ER Ki67 PR Her-2, 10 cases 10 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
114.00€ |
|
Pub |
LV2091 |
Liver cancer tissue array with normal liver tissue as control, including TNM, clinical stage and pathology grade, 208 cases 208 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
429.00€ |
|
Pub |
FDA902-2 |
FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, 15 cases 45 cores, replaced by FDA902b-2; ihc Anti-Actin confirmed
|
US Biomax |
|
858.00€ |
|
Pub |
PR484 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
162.00€ |
|
Pub |
HN803a |
Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
LC488 |
Lung cancer tissue array with matched adjacent lung tissue, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
BR243d |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
FMC281 |
Multiple tumor and corresponding normal frozen tissue (14 types) array, 14 cases 28 cores, previously named FMC401; ihc Anti-Actin confirmed
|
US Biomax |
|
394.00€ |
|
Pub |
BC01071a |
Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
CR1501 |
Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
FDA807 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
CR245 |
Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
T087a |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BC07014a |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
T175 |
Brain tumor tissue array with normal brain tissue as control, including pathology grade, 12 cases 24 cores, replacing T172; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
FRA781-2 |
FDA standard normal rat multiple organ frozen tissue array, slide two, 26 cases 78 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
FDA808a-1 |
Multiple organ normal tissue array, 72 cases 72 cores, replacing FDA808-1; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
OV961 |
Ovary tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
GL803a |
Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases 80 cores, replacing GL803; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
BR803a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
FDA999a |
Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA999; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
TH802a |
Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing TH802; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
T144 |
Pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
SK245 |
Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
FMC407b |
Multiple organ cancer frozen tissue array, including TNM information, 40 cases 40 cores, replacing FMC407; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
T045c |
Lung cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T045; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
ES244 |
Esophageal squamous cell carcinoma tissue array with matched adjacent esophageal tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
UT243 |
Endometrium cancer tissue array with matched adjacent endometrium tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BC11012a |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
T231a |
Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
PR483a |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed
|
US Biomax |
|
210.00€ |
|
Pub |
T104 |
Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BS17016a |
Brain glioblastoma tissue array, including pathology grade, 40 cases 80 cores, replacing BS17016; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
T014 |
Stomach cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BR243c |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
T203a |
Lymphatic tissue tumor test tissue array, with normal control tissue, 12 cases 24 cores, replacing T203; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
T086b |
Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
TH242 |
Thyroid cancer tissue array with matched adjacent thyroid tissue, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
T244 |
Soft tissue malignant tumor tissue array, including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
LV8010 |
Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
T113a |
Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T113; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
T125 |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
FMC402b |
Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replacing FMC402a; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
T388 |
Malignant melanoma test tissue array (4x (2x3)array), including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
T174a |
Brain tumor tissue array with normal brain tissue as control, including pathology grade, 6 cases 24 cores, replacing T171; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BRF401 |
Breast cancer frozen tissue array, with normal tissue, 40 cases 40 cores, Her-2 and ER PR IHC are supplied when purchase; ihc Anti-Actin confirmed
|
US Biomax |
|
742.00€ |
|
Pub |
RE1503 |
Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
FRA781-1 |
FDA standard normal rat multiple organ frozen tissue array, slide one, 26 cases 78 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
FDA808a |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
ST1004 |
Stomach adenocarcinoma with matched adjacent tissue array, including TNM and pathology grade, 55 cases 100 cores, replacing BC01114; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
T212a |
Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
PR242a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR242; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
KD961 |
Kidney tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
HN242a |
Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
CO802a |
Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
CO1502 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
ST483b |
Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed
|
US Biomax |
|
210.00€ |
|
Pub |
CO241a |
Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing CO241; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
BRN801a |
Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BRN801; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
FRA901a |
Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation, 45 cases 45 cores, 2 slides set, replacing FRA901; ihc Anti-Actin confirmed
|
US Biomax |
|
858.00€ |
|
Pub |
LC961 |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
BL244 |
Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
SO751 |
Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM and clinical stage, 39 cases 75 cores, replacing BC24021; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
GL806a |
Brain glioblastoma multiforme(GBM) tissue array, 40 cases 80 cores, replacing GL806; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
VLC12 |
Lung cancer tissue array, with TNM and grade info, 12 cases 12 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
BR243b |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
T024 |
Esophageal cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
FBN401 |
Normal human multiple organ frozen tissue array (20 organs in duplicate), 20 cases 40 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
278.00€ |
|
Pub |
LC1502 |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
MC6163 |
High-density tissue array of multiple organ tumor and normal tissue, with pathology grade, cllinical stage and TNM, 616 cases 616 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
811.00€ |
|
Pub |
MC809a |
Blastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing MC809; ihc Anti-Actin confirmed
|
US Biomax |
|
382.00€ |
|
Pub |
T086a |
Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T086b; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
T001a |
Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T001; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BC12011a |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed
|
US Biomax |
|
162.00€ |
|
Pub |
PR633 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
MC246 |
Multiple organ tumor with matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC244; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
T124 |
Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
FMC402a |
Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replaced by FMC402b; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
T034 |
Liver cancer test tissue array (4x (2x3) array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
PA242a |
Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
FBN407a |
Multiple organ normal frozen tissue array, 20 cases 40 cores, replaing FBN407; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
KD244 |
Kidney clear cell carcinoma tissue array with matched kidney adjacent tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
CO484a |
Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed
|
US Biomax |
|
210.00€ |
|
Pub |
PA961a |
Pancreatic cancer tissue array with normal pancreatic tissue, including TNM, clinical stage and pathology grade, 96 cases 96 cores, replacing PA961; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
MS481a |
Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases 48 cores, replacing MS481; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
ME241a |
Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases 24 cores, replacing ME241; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
ST483a |
Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
PR803a |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
T142a |
Pancreas tumor test tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing T142; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
FMC406c |
Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
PA483a |
Pancreatic cancer tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing PA483; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
PRF281 |
Prostate cancer frozen tissue array, with grade and Gleason scores and normal prostate tissue control, 28 cases 28 cores; ihc H&E and Anti-Actin confirmed
|
US Biomax |
|
742.35€ |
|
Pub |
OR601a |
Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
FRA901-2 |
Normal rat multiple organ (recommended by FDA) frozen tissue array, slide two, 15 cases 45 cores, replaced by FRA901a-2; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
LV487 |
Hepatocellular carcinoma tissue array with matched liver adjacent tissue, including TNM and pathology grade, 16 cases 48 cores,; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
TH809a |
Thyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases 80 cores, replacing TH809; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
BR243f |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
T343 |
Head & Neck cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
FMC409a |
Frozen multiple organ cancer tissue array, 20 cases 40 cores, replacing FMC409; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
CO243a |
Colon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO243; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
ST962 |
Stomach cancer tissue array, including clinical stage, TNM and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
ST2091 |
Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases 208 cores, replacing ST2001; ihc Anti-Actin confirmed
|
US Biomax |
|
487.00€ |
|
Pub |
BC041115a |
Lung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases 120 cores, replacing BC041115; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
T112a |
Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T112; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
SF961 |
Soft tissue tumor tissue array, including TNM and clinical stage, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
KD1501 |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
T385a |
Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
ON481 |
Oncocytoma tissue array, 24 cases 48 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
162.00€ |
|
Pub |
T173a |
Brain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T173; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
FDA808 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
BO244a |
Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
T089 |
Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
HN241a |
Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN241; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
CO1021 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
BR964 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
OV701 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
MC803a |
Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmed
|
US Biomax |
|
320.00€ |
|
Pub |
FRA901-1 |
FDA standard normal rat multiple organ frozen tissue array, slide one, 15 cases 45 cores, replaced by FRA901a-1; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
LC817 |
Lung cancer tissue array with matched lymph node metastatic tissue, including TNM, clinical stage and pathology grade, 40 cases 80 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
T074 |
Kidney cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
CO488 |
Colon adenocarcinoma with matched adjacent colon tissue array, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
ST1503 |
Stomach adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
CO804a |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replcing CO804; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
BR804a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
BR10010a |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme
|
US Biomax |
|
296.00€ |
|
Pub |
FBN406a |
Multiple organ normal frozen tissue array, 20 organs 40 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
394.00€ |
|
Pub |
T291a |
Myeloma tissue array with normal tissue as control, 6 cases 24 cores, replacing T291; ihc Anti-actin
|
US Biomax |
|
114.00€ |
|
Pub |
LV961 |
Hepatocellular carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores; ihc Anti-Cytokeratin (CK) confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
BC03011 |
Liver carcinoma (multi-tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010; ihc Anti-PCNA confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
FRA901a-2 |
Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-2; ihc Anti-Actin c
|
US Biomax |
|
626.00€ |
|
Pub |
CyFDA1 |
FDA multiple organ normal tissue array of cynomolgus monkey, 34 organs 99 cores, replacing CyFDA; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
PR951 |
Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases 95 cores, with TNM and Gleason scores, replaced by PR952; ihc Anti-PCNA confirmed
|
US Biomax |
|
487.00€ |
|
Pub |
FMO901-2 |
Normal mouse multiple organ frozen tissue array, for therapeutic and diagnostic antibody, 15 organs 45 cores, slide 2 of 2 tissue arrays; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
PR956 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR955; ihc Anti-Actin confir
|
US Biomax |
|
487.00€ |
|
Pub |
BR1505 |
Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases 150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin
|
US Biomax |
|
296.00€ |
|
Pub |
FRA901a-1 |
Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-1; ihc Anti-Actin c
|
US Biomax |
|
626.00€ |
|
Pub |
GL2083a |
Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing GL2083; ihc Anti-Cytokeratin (CK) confirmed
|
US Biomax |
|
487.00€ |
|
Pub |
FFE302a |
Multiple organ normal frozen tissue array, 15 organs 30 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
394.00€ |
|
Pub |
BC04011 |
Lung cancer tissue array, including pathology grade, 23 cases 63 cores, replaced by LC721; ihc Anti-Cytokeratin (CK) confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
PR807a |
Prostate cancer, hyperplasia and normal tissue array, including TNM and pathology grade, 79 cases 80 cores, replacing PR807; ihc Anti-Prostate Specific Antigen (PSA) confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
LY2082 |
Lymphoma survey tissue array (2 of 5), 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
LM801 |
Lymphoma (Hodgkin's and non Hodgkin's disease) tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
LY2087 |
Lymphoma tumor survey tissue array (2 of 3), 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
NHL802 |
Non Hodgkin's lymphoma tissue array, 42 cases 80 cores, no overlaps with NHL801, replaced by NHL803
|
US Biomax |
|
266.00€ |
|
Pub |
LY1001 |
Diffuse large B cell lymphoma tissue array, 100 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
ESC242 |
Esophagus cancer tissue array, 12 cases 24 cores; ihc H&E, IHC anti-Cytokeratin
|
US Biomax |
|
205.00€ |
|
Pub |
LY2081 |
Lymphoma tumor survey tissue array (1 of 5), with normal tissue, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
LM721 |
Lymphoma and normal lymph node tissue array, 24 cases 72 cores
|
US Biomax |
|
266.00€ |
|
Pub |
LY2086 |
Lymphoma tumor tissue array, 208 cases 208 cores
|
US Biomax |
|
633.00€ |
|
Pub |
T204 |
Lymphoma test tissue array, with normal tissue as control, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
HL801 |
Hodgkin's lymphoma tissue array, 45 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
NHL401 |
Lymphoma, multiple myeloma and lymph node tissue array, 40 cases 40 cores
|
US Biomax |
|
266.00€ |
|
Pub |
CO952 |
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores, replacing CO951; ihc Anti-Cytokeratin (CK) confi
|
US Biomax |
|
429.00€ |
|
Pub |
NHL801 |
Non Hodgkin's lymphoma tissue array, 42 cases 80 cores, no overlaps with NHL802
|
US Biomax |
|
266.00€ |
|
Pub |
LY6161 |
High density lymphoma and normal lymph node tissue array, 322 cases 616 cores
|
US Biomax |
|
753.00€ |
|
Pub |
LY1501 |
Lymphoma tumor tissue array, 75 cases 150 cores
|
US Biomax |
|
380.00€ |
|
Pub |
CMA241a |
Human tumor cell array, 12 cell lines 24 cores, replacing CMA241; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
TE802 |
Testis seminoma and lymphoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
LYM181 |
Lymphoma tissue array, 18 cases 18 cores
|
US Biomax |
|
166.00€ |
|
Pub |
LY2085 |
Lymphoma tumor survey tissue array (5 of 5), 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
HL481 |
Hodgkin's lymphoma tumor tissue array, 48 cases 48 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LM803 |
Lymphoma and normal lymph node tissue array, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
NHL483 |
Non Hodgkin's lymphoma tumor tissue array, 48 cases 48 cores
|
US Biomax |
|
231.00€ |
|
Pub |
NHL803b |
Lymphoma tissue array, 80 cases 80 cores, replacing NHL803
|
US Biomax |
|
321.00€ |
|
Pub |
FDA901-2 |
FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide two); ihc Anti-Actin confirmed
|
US Biomax |
|
858.00€ |
|
Pub |
LM482 |
Myeloma, lymphoma and normal tissue array, 48 cases 48 cores
|
US Biomax |
|
266.00€ |
|
Pub |
LYM1502 |
Lymphoma mid density tissue array, non overlapping with LYM1501, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
LY2084 |
Lymphoma tumor survey tissue array (4 of 5), 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
HER2 |
Her-2 IHC Bio-marker control TMA, for CAP proficiency test survey, with breast invasive ductal carcinoma, 10 cases 10 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
114.00€ |
|
Pub |
LM802 |
Lymphoma (Hodgkin's and non Hodgkin's disease) tissue array, 80 cases 80 cores, replaced by NHL803
|
US Biomax |
|
266.00€ |
|
Pub |
SO802 |
Malignant fibrohistiocytoma tissue array, 80 cases 80 cores; ihc CD68 confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
NHL482 |
Lymphoma tissue array, 48 cases 48 cores, replacing NHL481
|
US Biomax |
|
189.00€ |
|
Pub |
BR1503a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases 150 cores, replacing BR1503; ihc Anti-
|
US Biomax |
|
296.00€ |
|
Pub |
NHL803 |
Lymphoma tissue array, 80 cases 80 cores, replacing LM802
|
US Biomax |
|
266.00€ |
|
Pub |
LY121 |
Diffuse large B cell lymphoma tissue array, 12 cases 12 cores
|
US Biomax |
|
189.00€ |
|
Pub |
FDA901-1 |
FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide one); ihc Anti-Actin confirmed
|
US Biomax |
|
858.00€ |
|
Pub |
LM481 |
Multiple lymphoma tissue array with normal tissues, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LYM1501 |
Lymphoma mid density tissue array, non overlapping with LYM1502, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BS20011 |
Lymphoma tissue array, 30 cases 30 cores, replaced by NHL481
|
US Biomax |
|
189.00€ |
|
Pub |
LY2083 |
Lymphoma survey tissue array (3 of 5), 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T201 |
Lymphoma test tissue array, with normal lymph node control tissues, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
NHL481 |
Lymphoma tissue array, 48 cases 48 cores, replaced by NHL482
|
US Biomax |
|
189.00€ |
|
Pub |
LY2088 |
Lymphoma tumor tissue array, 208 cases 208 cores
|
US Biomax |
|
558.00€ |
|
Pub |
LM241 |
Multiple lymphoma tissue array with normal tissues, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
PA2072 |
Pancreas cancer tissue array, with normal tissue, including TNM and pathology grade, 69 cases 207 cores, replacing PA207
|
US Biomax |
|
456.00€ |
|
Pub |
TH809 |
Thyroid cancer metastasis tissue array, 40 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BC21014 |
Skin malignant tumor tissue array, 78 cases 78 cores, replacing BC21011
|
US Biomax |
|
231.00€ |
|
Pub |
ST8011 |
Gastric cardia disease spectrum (cardia cancer progression) tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
OV242 |
Multiple ovarian cancer test tissue array with unmatched normal adjacent tissues, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
T342 |
Head & Neck cancer test tissue array, with normal tongue and epiglottis control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
CXC481 |
Cervix cancer and normal tissue array, 16 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BR1922 |
Late stage breast cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
PR807 |
Prostate cancer, hyperplasia and normal tissue array, with stage (Gleason Scores) and grade info, 79 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
LC1201 |
Lung disease spectrum tissue array, 116 cases 120 cores, with grade and stage information
|
US Biomax |
|
278.00€ |
|
Pub |
ES1001 |
Esophagus cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
NPC961 |
Nasopharyngeal carcinoma tissue array, non overlapping with NPC962, >50 cases 96 cores
|
US Biomax |
|
344.00€ |
|
Pub |
T153 |
Thyroid cancer test tissue array, with normal thyroid gland tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC01022 |
Stomach adenocarcinoma (combination of adjacent and normal) tissue array, 21 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
COC962 |
Colon cancer and normal tissue array, non overlapping with COC961, 48 cases 96 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BRC2281 |
High density breast cancer tissue array, 228 cases 228 cores
|
US Biomax |
|
0.00€ |
|
Pub |
MC616 |
High density lung, breast, brain and colon cancer array, with stage, grade and normal tissue array, 308 cases 616 cores
|
US Biomax |
|
753.00€ |
|
Pub |
KD2086 |
Kidney cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
SK482 |
Multiple skin cancer tissue array with 4 normal tissue control from autopsy, 24 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
FMC409 |
Multiple organ cancer frozen tissue array, 20 cases 40 cores replacing FMC401
|
US Biomax |
|
281.00€ |
|
Pub |
GI101 |
Multiple organ gastrointestinal (GI) tract cancer metastasis tissue array, 50 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
LC806 |
Multiple types of lung carcinoma tissue array, 80 cases 80 cores, replacing BC04013
|
US Biomax |
|
231.00€ |
|
Pub |
MNO341 |
Antibody cross reactivity testing tissue array, 33 cases 34 cores
|
US Biomax |
|
118.00€ |
|
Pub |
LV1921 |
Liver late stage tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CO243 |
Colon cancer tissue array with normal tissue controls, 9 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
PA801 |
Multiple pancreatic cancer tissue array with unmatched normal adjacent tissue, with stage and grade info, 70 cases 80 cores, replaced by PA802
|
US Biomax |
|
231.00€ |
|
Pub |
TR011 |
Rat normal stomach test tissue array, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BR602 |
Breast tumor and normal tissue array, with TNM data, 25 cases 60 cores
|
US Biomax |
|
0.00€ |
|
Pub |
FDA804 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies
|
US Biomax |
|
278.00€ |
|
Pub |
LC1921 |
High density non small cell lung carcinoma (NSCLC) tissue array, with stage and grade info, 192 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BS01032 |
Stomach adenocarcinoma (grade II) tissue array, 63 cases 63 cores, replaced by ST808
|
US Biomax |
|
160.00€ |
|
Pub |
ST961 |
Stomach adenocarcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores
|
US Biomax |
|
321.00€ |
|
Pub |
BC08016 |
Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BR803
|
US Biomax |
|
160.00€ |
|
Pub |
BR20822 |
Breast tumor survey tissue array (16 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
ES482 |
Multiple esophagus cancer tissue array with unmatched normal adjacent tissues, 48 cases 48 cores, with grade and stage data
|
US Biomax |
|
160.00€ |
|
Pub |
BC03011 |
Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010
|
US Biomax |
|
160.00€ |
|
Pub |
CR241 |
Cervix cancer test tissue array with self matching or unmatched normal adjacent tissue, 11 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BN961 |
Normal human tissue panel (24 organs) with two serial tissue array sections in parallel, 24 cases 102 cores, replacing BN861
|
US Biomax |
|
266.00€ |
|
Pub |
IC00011b |
Gastric carcinoma, gastritis with intestinal metaplasia tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing IC00011
|
US Biomax |
|
321.00€ |
|
Pub |
MC808 |
Multiple tumor tissue array 58 different tumors and their corresponding normal tissues with TNM data, 58 cases 96 cores
|
US Biomax |
|
266.00€ |
|
Pub |
KD802 |
Kidney multiple cancer tissue array (clear, granular and transitional cell carcinoma, etc), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
RE483 |
Rectum adenocarcinoma tissue array with matched adjacent rectum tissue, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
188.00€ |
|
Pub |
SM2081 |
Small intestine disease (cancer progression) spectrum tissue array, 95 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
FRB281f |
Normal female rabbit multiple organ frozen tissue array, 28 cases 28 cores
|
US Biomax |
|
293.00€ |
|
Pub |
LV2161 |
Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 216 cases 216 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T085 |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T088
|
US Biomax |
|
88.00€ |
|
Pub |
CO721 |
Colon cancer tissue array with stage and grade info, 24 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
UT501 |
Endometrioid adenocarcinoma and normal tissue array with TNM and grade, 50 cases 50 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BL801 |
Bladder cancer tissue array, with adjacent normal tissue, pathology grade and TNM stage, 53 cases 80 cores, replaced by BL806
|
US Biomax |
|
266.00€ |
|
Pub |
BR8013 |
Advanced breast cancer and normal tissue array, with stage, TNM and pathology grade info, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LC2086 |
Normal lung tissue array, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BS04111 |
Lung small cell carcinoma tissue array, 33 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
T0013 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
CNS2081 |
Central nerve disease spectrum (central nerve tumor progression) tissue array, 104 cases 208 cores
|
US Biomax |
|
516.00€ |
|
Pub |
TET481 |
Human testis cancer tissue array, 24 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BC111110 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR2085a |
High density (188 cases 208 cores), multiple types of breast cancer of infiltrating ductal, lobular carcinoma and normal breast tissue array, replaced by BR2085c.
|
US Biomax |
|
456.00€ |
|
Pub |
ES808 |
Esophagus cancer and normal tissue array, with TNM and grade info, 78 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
ST2083 |
Stomach cancer and normal stomach tissue array with stage and grade, 69 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
OV20810 |
Ovary cancer survey tissue array (1 of 4), with normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T241 |
Soft tissue cancer test tissue array, with normal soft tissue control tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC041115 |
Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores
|
US Biomax |
|
278.00€ |
|
Pub |
CR802 |
Cervical cancer tissue array, matched or unmatched tumor and adjacent normal tissue, 74 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
PR631 |
Prostatic carcinoma tissue array with 3 cases of normal prostate tissue from autopsy, 33 cases 63 cores, with grade and Gleason scores
|
US Biomax |
|
266.00€ |
|
Pub |
KIC962 |
Kidney cancer and normal tissue array, non overlapping with KIC961, 48 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
REC1501 |
Rectal cancer mid density tissue array, non overlapping with REC1502 or REC1503, 75 cases 150 cores
|
US Biomax |
|
0.00€ |
|
Pub |
SO8011 |
Smooth muscle and striated muscle disease spectrum (cancer progression) tissue array, 80 cases 80 cores
|
US Biomax |
|
278.00€ |
|
Pub |
GL811 |
Brain tumor and normal tissue array, with pathology grade, 27 cases 81 cores, replacing BS17011
|
US Biomax |
|
266.00€ |
|
Pub |
LV723 |
Liver cancer and adjacent normal tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC03013
|
US Biomax |
|
231.00€ |
|
Pub |
T112 |
Ovary cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC00111 |
Multiple organ normal and diseased tissue array (replaced by MCN601), 54 cases 60 cores
|
US Biomax |
|
231.00€ |
|
Pub |
HN811 |
Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases 81 cores, replacing BC34111
|
US Biomax |
|
266.00€ |
|
Pub |
CO809 |
Colon polyp and colitis tissue array, including colon adenoma and normal tissue, 80 cases 80 cores
|
US Biomax |
|
263.00€ |
|
Pub |
BR809 |
Breast invasive lobular carcinoma tissue array with adjacent normal tissue, 79 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
MC244 |
Multiple organ cancer and normal adjacent tissue array, replacing MC241, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
LC501 |
Tissue array of multi type lung cancer and normal tissue with TNM and grade, 50 cases 50 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BS17018 |
Brain glioblastoma tissue array, 33 cases 63 cores, replaced by GL805
|
US Biomax |
|
231.00€ |
|
Pub |
LUC1502 |
Lung cancer mid density tissue array, non overlapping with LUC1501 or LUC1503, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
T022 |
Esophageal cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
CO20812 |
Colon tumor survey tissue array (2 of 4), including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BR953 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952
|
US Biomax |
|
456.00€ |
|
Pub |
KD1002 |
Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LC722 |
Lung cancer and normal tissue array, with TNM and grade data, 24 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LUC961 |
Lung cancer and normal tissue array, without overlapping with LUC962, 48 cases 96 cores
|
US Biomax |
|
189.00€ |
|
Pub |
PA241b |
Pancreas adenocarcinoma tissue array with matched adjacent normal pancreas tissue, including TNM and pathology grade, 6 cases 24 cores, replacing PA241
|
US Biomax |
|
99.00€ |
|
Pub |
THY761 |
Thymus disease spectrum (thymic cancer progression) tissue array, 76 cases 76 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BC27011 |
Multiple organs, diseased tissue array of oral cavity, 47 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BR246a |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing BR246
|
US Biomax |
|
99.00€ |
|
Pub |
OV484 |
Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores
|
US Biomax |
|
231.00€ |
|
Pub |
T385 |
Malignant melanoma test tissue array, with normal skin tissue as control, including TNM and clinical stage, 6 cases 24 cores, replaced by T386
|
US Biomax |
|
88.00€ |
|
Pub |
BC07011 |
Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replaced by BC07013
|
US Biomax |
|
160.00€ |
|
Pub |
BR20812 |
Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
PR952 |
Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases 95 cores, with TNM and Gleason scores, replaced by PR953
|
US Biomax |
|
314.00€ |
|
Pub |
OM601 |
Metastatic carcinoma of epiploon tissue array, 60 cases 60 cores
|
US Biomax |
|
266.00€ |
|
Pub |
LVC481 |
Liver cancer and normal tissue array, non overlapping with LVC482, 16 cases 48 cores
|
US Biomax |
|
166.00€ |
|
Pub |
T173 |
Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC01081 |
Adenocarcinoma of stomach, colon and rectum high density tissue array, 556 cases 616 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CR1921 |
Middle advanced stage uterine cervix cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BN117 |
Multiple organ normal tissue array, 45 cases 45 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BRC961 |
Breast cancer array with normal and other non malignant breast tissues, non overlapping with BRC962, with AR ER PR Her 2(neu) IHC results, 48 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
MC643 |
Multiple cancer tissue array II, 6 common types of cancer and some of matched normal tissues, with TNM data, 58 cases 66 cores
|
US Biomax |
|
0.00€ |
|
Pub |
KD242 |
Multiple Kidney cancer test tissue array with unmatched normal adjacent tissue, 10 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
SK801b |
Skin squamous cell carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing SK801
|
US Biomax |
|
321.00€ |
|
Pub |
FMS151 |
Brains of multiple species frozen tissue array, 14 cases 15 cores
|
US Biomax |
|
293.00€ |
|
Pub |
GIST801 |
Gastrointestinal stromal tumor (GIST) tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LC811 |
Lung cancer tissue array with normal tissues, 80 cases 80 cores
|
US Biomax |
|
278.00€ |
|
Pub |
MO01011 |
Mouse stomach tissue array, 100 cases 100 cores, 50 from different male, 50 from different female
|
US Biomax |
|
160.00€ |
|
Pub |
LV20811 |
Liver cancer survey tissue array (3 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CO483 |
Multiple colon cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade information
|
US Biomax |
|
160.00€ |
|
Pub |
UGD381 |
Urinary genital system disease tissue array, 38 cases 38 cores
|
US Biomax |
|
166.00€ |
|
Pub |
BR722 |
Breast disease spectrum tissue array, 66 cases 72 cores, including normal, precancerous and cancer in different stages
|
US Biomax |
|
231.00€ |
|
Pub |
FDA807-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA806 2
|
US Biomax |
|
336.00€ |
|
Pub |
LC20811 |
Lung cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BS02041 |
Esophagus squamous cell carcinoma (grade III) tissue array, 23 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
STC1501 |
Stomach cancer mid density tissue array, non overlapping with STC1502 or STC1503, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
OV808 |
Ovarian cancer metastasis tissue array, 40 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BC081116 |
Breast cancer (IDC) tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores
|
US Biomax |
|
278.00€ |
|
Pub |
BR20827 |
Breast tumor survey tissue array (21 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
ES781 |
Esophagus cancer tissue array, including TNM and pathology grade, 26 cases 78 cores, replacing BC02111
|
US Biomax |
|
266.00€ |
|
Pub |
ST1001 |
Stomach disease spectrum (stomach cancer progression) tissue array, 100 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
OV1001 |
Ovarian disease spectrum (ovarian cancer progression) tissue array, 100 cases 100 cores, replaced by OV1005
|
US Biomax |
|
231.00€ |
|
Pub |
BC03119 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores
|
US Biomax |
|
278.00€ |
|
Pub |
CR481 |
Cervical cancer tissue array with normal adjacent tissues, 24 cases 48 cores, with grade and stage data
|
US Biomax |
|
160.00€ |
|
Pub |
BO244 |
Human normal bone and osteosarcoma tissue array, 12 cases 24 cores, replacing BO243
|
US Biomax |
|
100.00€ |
|
Pub |
MC963 |
Multiple cancer tissue array with four 24 core array squares mounted on glass, 12 cases 96 cores
|
US Biomax |
|
266.00€ |
|
Pub |
KD808 |
Mid advanced stage kidney cancer and metastatic carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
RE723 |
Rectal adenocarcinoma (grade 2) tissue array, with stage, TNM and grade, 24 cases 72 cores, replacing BS06031
|
US Biomax |
|
231.00€ |
|
Pub |
SO1001 |
Peripheral nerve disease spectrum (peripheroneural cancer progression) tissue array, 50 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
GL722 |
Brain glioma (astrocytoma) tissue array, 24 cases 72 cores
|
US Biomax |
|
266.00€ |
|
Pub |
LV245 |
Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
T088 |
Breast cancer tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores, replacing T085
|
US Biomax |
|
88.00€ |
|
Pub |
BB01011 |
Gastric ulcer tissue array, 14 cases 24 cores
|
US Biomax |
|
160.00€ |
|
Pub |
HN241 |
Head & Neck cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
CO726 |
Metastatic colon carcinoma tissue array, 24 cases 72 cores, replacing BC050112
|
US Biomax |
|
266.00€ |
|
Pub |
BL806 |
Bladder cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BL801
|
US Biomax |
|
266.00€ |
|
Pub |
BR8018 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing BR808, BC08014
|
US Biomax |
|
266.00€ |
|
Pub |
FDA995 |
FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replaced by FDA997
|
US Biomax |
|
278.00€ |
|
Pub |
LC241 |
Non small cell lung carcinoma (NSCLC) test tissue array, with self matching normal adjacent tissue, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BS06011 |
Rectum adenocarcinoma tissue array, 22 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LN802 |
Multiple organ lymph tissue array, 80 cases 80 cores, replacing LN801
|
US Biomax |
|
231.00€ |
|
Pub |
T004 |
Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
CO1004 |
Colon carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
TH721 |
Thyroid cancer and normal tissue array with clinical stage and grade info, 24 cases 72 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BC17012 |
Medulloblastoma of brain tissue array, 100 cases 100 cores
|
US Biomax |
|
277.00€ |
|
Pub |
BR2088 |
Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
OV2082 |
Ovary cancer tissue array with normal tissues, with TNM and grade info, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T262 |
Bone cancer test tissue array, with normal control tissue, including TNM and clinical stage, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC05002 |
Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
CR811 |
Cervical cancer tissue array with normal tissues from autopsy, 40 cases 80 cores, with grade and TNM data
|
US Biomax |
|
231.00€ |
|
Pub |
PR752 |
Prostate cancer and hyperplasia tissue array, including TNM and pathology grade, 75 cases 75 cores
|
US Biomax |
|
266.00€ |
|
Pub |
REC961 |
Rectum cancer and normal tissue array, non overlapping with REC962, 48 cases 96 cores
|
US Biomax |
|
0.00€ |
|
Pub |
SO805 |
Neurilemmoma of peripheral nerve tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LV8012 |
Mid advanced stage liver cancer tissue array, including TNM and pathology grade, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
T122 |
Bladder cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BN03011 |
Normal liver tissue array (multi sites), 20 cases 63 cores, replaced by LVN801
|
US Biomax |
|
160.00€ |
|
Pub |
PR802 |
Prostate carcinoma tissue array, 80 cases 80 cores, no overlaps with PR801, replaced by PR8010
|
US Biomax |
|
231.00€ |
|
Pub |
LC1004 |
Lung carcinoma (multi tissue combined panel) tissue array, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
RhFDA1 |
FDA normal organ tissue array of rhesus monkey, 99 cases 99 cores
|
US Biomax |
|
278.00€ |
|
Pub |
SP1001 |
Spleen disease spectrum (splenic cancer progression) tissue array, 50 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
LV805 |
Liver cirrhosis and hepatitis tissue array, 80 cases 80 cores, replacing IC03001
|
US Biomax |
|
231.00€ |
|
Pub |
BC00116 |
Carcinoma with adjacent tissue combined panel tissue array, 44 cases 48 cores
|
US Biomax |
|
231.00€ |
|
Pub |
COC1502 |
Colon cancer mid density tissue array, non overlapping with either COC1501 or COC1503 75 cases 150 cores
|
US Biomax |
|
0.00€ |
|
Pub |
BN06012 |
Normal rectum tissue (multi sites) tissue array, 70 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
MC5002 |
High density multiple organ tumor tissue array, with adjacent normal tissue, information of TNM, stage and grade, 500 cases 500 cores, replacing MC5001
|
US Biomax |
|
634.00€ |
|
Pub |
KD20811 |
Kidney cancer survey tissue array (2 of 3), including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
SK241 |
Skin cancer test tissue array with unmatched normal adjacent tissues, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
T043 |
Lung cancer test tissue array, with normal lung tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
CO208b |
TMA Block of high density (70 cases 208 cores), multiple colon cancer (1 4 grade) and normal colon tissue array block
|
US Biomax |
|
40 981.00€ |
|
Pub |
PA482 |
Multiple pancreatic cancer tissue array with 4 normal tissue control from autopsy, 24 cases 48 cores, with TNM data
|
US Biomax |
|
160.00€ |
|
Pub |
BC35111 |
Retinoblastoma and normal adjacent tissue array, 17 cases 34 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BR482 |
Multiple breast cancer tissue array with normal tissues from autopsy, 24 cases 48 cores, with stage and grade info
|
US Biomax |
|
160.00€ |
|
Pub |
OV641 |
Ovary cancer tissue array, 64 cases 66 cores, with TNM data
|
US Biomax |
|
0.00€ |
|
Pub |
T392 |
Mesothelioma test tissue array, with normal mesothelial control tissue, including TNM and clinical stage, 6 cases 24 cores, replacing T391
|
US Biomax |
|
88.00€ |
|
Pub |
BC07015 |
Multiple type kidney cancer tissue array with normal tissues, 71 cases 72 cores, replacing BC07012
|
US Biomax |
|
231.00€ |
|
Pub |
BR20817 |
Breast tumor survey tissue array (11 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
PRC481 |
Prostate cancer tissue array, 24 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
ES2082 |
High density esophageal cancer and normal tissue array, with TNM and grade info, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
OR481 |
Oral cavity (tongue and parotid) cancer tissue array, 48 cases 48 cores.
|
US Biomax |
|
160.00€ |
|
Pub |
BC02021 |
Esophagus squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores
|
US Biomax |
|
160.00€ |
|
Pub |
CR2084 |
Cervical cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BRM481 |
Tissue array of breast carcinoma metastasis in lymph nodes, 24 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
MC803 |
Retinoblastoma, nephroblastoma, neuroblastoma and leukemia tissue array, 40 cases 80 cores
|
US Biomax |
|
314.00€ |
|
Pub |
KD483 |
Multiple Kidney cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade data
|
US Biomax |
|
160.00€ |
|
Pub |
RE2081 |
Rectum disease spectrum (rectal cancer progression) tissue array, 98 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
FRA901 |
Normal rat multiple organ (recommended by FDA) frozen tissue array, slide one, 15 cases 45 cores
|
US Biomax |
|
331.00€ |
|
Pub |
GL1921 |
Mid advanced stage brain tumor tissue array, including pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
LC816 |
Advanced lung cancer and normal tissue array, with stage TNM and grade info, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
MO1002 |
Mouse spleen tissue array, 100 cases 100 cores, 50 male and 50 female, replacing MO32011
|
US Biomax |
|
189.00€ |
|
Pub |
LV2085 |
Liver cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T073 |
Kidney cancer test tissue array, with normal kidney tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
CO487 |
Colon adenocarcinoma with matched adjacent colon tissue array, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BL241 |
Bladder cancer tissue array with self matching normal adjacent tissues, 10 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BR727 |
Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases 72 cores, replacing BS08011
|
US Biomax |
|
231.00€ |
|
Pub |
LC20816 |
Lung cancer tissue array (5 of 5), including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BS04011 |
Lung squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores, replaced by LC808
|
US Biomax |
|
160.00€ |
|
Pub |
LM208 |
High density tissue microarray of Hodgkin's Disease, Non Hodgkin's lymphoma and normal lymph node tissues, 69 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
STC961 |
Stomach cancer and normal tissue array, non overlapping with STC962, 48 cases 96 cores
|
US Biomax |
|
189.00€ |
|
Pub |
CLC601 |
Colon cancer and lung cancer tissue array, including TNM and pathology grade, 60 cases 60 cores
|
US Biomax |
|
266.00€ |
|
Pub |
OVC1021 |
Ovary cancer tissue array, 102 cases 102 cores
|
US Biomax |
|
225.00€ |
|
Pub |
TE241 |
Testis cancer tissue array with unmatched normal adjacent tissues, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC10025 |
Cervical cancer and normal tissue array, 54 cases 54 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR20831 |
Breast tumor survey tissue array (25 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
EMC1501 |
Endometrial cancer mid density tissue array, non overlapping with EMC1502, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
ES802 |
Esophageal squamous cell carcinoma tissue array, grade I III, 40 cases 80 cores, no overlaps with ES801
|
US Biomax |
|
231.00€ |
|
Pub |
ST1502 |
Stomach adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
321.00€ |
|
Pub |
LY802 |
Lymph node metastatic squamous cell carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BC04014 |
Non small cell lung carcinoma (NSCLC) tissue array, 63 cases 63 cores, replaced by LC807
|
US Biomax |
|
160.00€ |
|
Pub |
CR501 |
Cervical cancer and normal tissue array with TNM and grade, 50 cases 50 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BR01015 |
Multiple organ, normal tissue array, 8 normal tissues, 160 cases 160 cores, replacing BR01011
|
US Biomax |
|
278.00€ |
|
Pub |
RE804 |
Rectal disease spectrum (rectum cancer progression) tissue array, 75 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
SO241 |
Soft tissue cancer tissue array with unmatched normal adjacent tissues, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
GL804 |
Brain tumor and normal tissue array with grade and TNM data, 40 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
MT801 |
Multiple organ cancer metastasis tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
LV485 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores
|
US Biomax |
|
397.00€ |
|
Pub |
BC000119 |
Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores
|
US Biomax |
|
456.00€ |
|
Pub |
HN482 |
Multiple Head & Neck cancer tissue array with normal tissue from autopsy, 48 cases 48 cores with stage and grade data, replaced by HN483
|
US Biomax |
|
160.00€ |
|
Pub |
CO804 |
Multiple types of colon carcinoma tissue array (replacing BC05011), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
VA1001 |
Vermiform appendix disease spectrum (vermiform appendix tumor progression) tissue array, 50 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BM241 |
Bone marrow tissue array, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BR804 |
Breast tumor tissue array, with matched tumor and adjacent normal tissue, replacing BR801, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
FDG281f |
Normal dog multiple organ frozen tissue array, 28 cases 28 cores
|
US Biomax |
|
199.00€ |
|
Pub |
LC483 |
Multiple lung cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BS09011 |
Uteral leiomyoma (hysteromyoma) tissue array, 30 cases 60 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LP801 |
Larynx and pharynx cancer tissue array, with matched adjacent normal tissue, 70 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
T009 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
CO1922 |
Advanced colon tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
TH803 |
Thyroid papillary cancer tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC19015 |
Prostate carcinoma tissue array, 9 cases 27 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BR242 |
Multiple breast cancer test tissue array with unmatched normal adjacent tissues, 12 cases 24 cores, replaced by BR244
|
US Biomax |
|
88.00€ |
|
Pub |
RA161 |
Multiple organs normal tissue array of rat, 8 cases 16 cores
|
US Biomax |
|
189.00€ |
|
Pub |
ST485 |
Stomach cancer and matched adjacent tissue array, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
OV2087 |
Ovary cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BC05022 |
Colon adenocarcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores, no overlapping with BC05021
|
US Biomax |
|
231.00€ |
|
Pub |
BR1502 |
Breast cancer mid density tissue array, wiht AR ER PR Her 2 P53 EGFR Ki67 IHC results, 75 cases 150 cores, replaced by BR1503
|
US Biomax |
|
278.00€ |
|
Pub |
ST801 |
Stomach cancer tissue array, with matched adjacent normal tissue, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
T323 |
Spleen tumor tissue array, with normal tissue, including TNM, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC05118 |
Colon cancer and matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
CXC241 |
Cervical cancer tissue array, 12 cases 24 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BR1921 |
High density breast invasive ductal and lobular carcinoma tissue array with normal tissues, grading and staging data,192 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
PR806 |
Prostate adenocarcinoma and normal tissue array with stage and Gleason Scores, 40 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
LC1009 |
Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
NPC481 |
Nasopharyngeal carcinoma tissue array, 48 cases 49 cores
|
US Biomax |
|
189.00€ |
|
Pub |
T151 |
Thyroid cancer test tissue array, with normal thyroid control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC01014 |
Stomach carcinoma tissue array (multi tissue combined panel), 71 cases 72 cores, replaced by ST807
|
US Biomax |
|
231.00€ |
|
Pub |
COC961 |
Colon cancer and normal tissue array, non overlapping with COC962 48 cases 96 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BN1002 |
Multiple organ (20) normal tissue array, 100 cases 100 cores, replacing BN1001
|
US Biomax |
|
266.00€ |
|
Pub |
BRC1503 |
Breast cancer mid density tissue array, non overlapping with BRC1501 or BRC1502, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
MC601 |
Multi organ cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores
|
US Biomax |
|
231.00€ |
|
Pub |
KD2085 |
Kidney cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
SK481 |
Skin cancer tissue array with corresponding (unmatched) normal adjacent tissues, 24 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
FMC408 |
Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores
|
US Biomax |
|
167.00€ |
|
Pub |
LC805 |
Lung large cell carcinoma and bronchioloalveolar carcinoma tissue array, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
PA722 |
Pancreatic cancer and normal tissue array, with TNM and pathology grade, 24 cases 72 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BCN963 |
Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases 96 cores, replacing BCN961
|
US Biomax |
|
266.00€ |
|
Pub |
FDA803 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies.
|
US Biomax |
|
278.00€ |
|
Pub |
BS01012 |
Stomach adenocarcinoma tissue array, 72 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
ST812 |
Stomach cancer tissue array with normal tissues from autopsy, with clinical stage (TNM) and pathology grade info, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
OV803 |
Ovarian adenocarcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
T461 |
Thymus cancer test tissue array, with normal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC08015 |
Breast carcinoma (multi tissue combined panel) tissue array, 22 cases 63 cores, replaced by BR728
|
US Biomax |
|
160.00€ |
|
Pub |
BR20821 |
Breast tumor survey tissue array (15 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T195 |
Prostate adenocarcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, 2 serial sections, replacing T192
|
US Biomax |
|
113.00€ |
|
Pub |